BioCentury
ARTICLE | Company News

Management Tracks

February 24, 2017 11:54 PM UTC

Celgene Corp. (NASDAQ:CELG) said President and COO Jacqualyn Fouse will retire on June 30. Scott Smith will succeed Fouse effective April 1. He is president of global inflammation and immunology. Terrie Curran will be promoted to president of global inflammation and immunology from head of worldwide commercial markets for inflammation and immunology.

Epigenetics company Storm Therapeutics Ltd. (Cambridge, U.K.) named Keith Blundy CEO. He was CEO at Cancer Research Technology Ltd. (London, U.K.)...